Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Clinical trial NCT07102394 · RECRUITING

Trial details

NCT number: NCT07102394
Sponsor: Johns Hopkins University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

NF1 Neurofibromatosis Cutaneous Neurofibroma Neurofibroma Von Recklinghausen Disease Neurofibromas

Start date: 2026-02-01
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.